Newly released data from the fertility supplements market analyzed by FMI estimates that the fertility supplements market enjoyed year-on-year (YoY) growth of 8.3% in 2021 to total 243,820 MT. The fertility supplements market is expected to witness a prominent growth rate of a CAGR of 8.3% to reach the value of US$ 4,382 Mn in 2031.
Fertility supplements business research performed by FMI covers crucial findings such as the latest developments by key producers and projected production capacity, the current pricing of various levels of the supply chain, and price optimization plan across the value chain, as well as an economic evaluation of fertility supplements manufacturing.
Download Sample Copy of Report [email protected]
The report discusses some of the more crucial factors chalking the market’s growth trajectory. It makes observation on prevailing trends and gauges the impact of the same on the overall market. This observation is supported by relevant data, graphs, infograph and expert opinions to offer a holistic study on the global fertility supplements market.
It includes in-depth insights into the market. Some of these are:
- The estimated value of the market was at US$ 1.47 Bn in 2019. Through the course of the report’s forecast period, the market is exhibited to show a steady pace of growth.
- Regionally, North America is the largest market for fertility supplements in the world.
- Asia Pacific follows closely, emerging as second-leading regional market.
- Through the course of the forecast period, the APEJ market is expected to report growth at the highest pace.
- In terms of ingredient, consumers seem to prefer natural ones more than the rest.
Rising Awareness about Importance Overall Well-being among Consumers is Enabling Growth
Lifestyle prevalent today does more harm to common man than ever before. According to the American Society for Reproductive Medicine, a considerable section of both men and women of reproductive age in the U.S. smoke cigarettes. Cigarette smoking has harmful impact on the overall health and wellbeing of an individual.
It also may adversely impact their fertility. Even the latest technologies might find it difficult to help a women conceive if she is exposed to excessive smoking. A rising awareness about the ongoing situation, coupled with information on potential cures will favour the expansion of the fertility supplements market.
The same factor, which is rising degree of awareness, is likely to pave way for the market’s growth in emerging economies as well.
Who is Winning?
Some of the leading players operating in the fertility supplements market are
- Fertility Nutraceuticals LLC
- Exeltis USA, Inc.
- TTK HealthCare Ltd.
- PregPrep LLC
- Orthomol pharmazeutische Vertriebs GmbH
- Active Bio Life Science GmbH
- Fairhaven Health, LLC
- Lenus Pharma GesmbH
- ZenithNutrition, and INVO Bioscience.
As a result of increasing competition, leading manufacturers are focusing on expanding their product portfolio and improving sourcing process. Their expansion strategies include investment in research and development activities and product launches. These companies are particularly focusing on catering to changing consumer preference across various nations.
In addition to this, mergers and acquisition remains a popular strategy among market players. Companies intend to expand their regional footprint through strategic collaborations.
Ask an Analyst, About this [email protected]
Get Valuable Insights into Fertility Supplements Market
Future Market Insights, in its new report, presents an unbiased analysis of the global fertility supplements market, covering historical demand data and forecast figures for the period between 2020 and 2030. The study divulges compelling insights into growth witnessed in the market. In terms of ingredient, the market can be categorized into natural, synthetic and blend.
On the basis of product, the market covers capsules, powders, soft gels, liquid and others. Men and women make the key end users in the market. Based on distribution channel, the market can be bifurcated into prescribed and over the counter. Regionally, the market can be segmented into North America, Europe, Latin America, Asia Pacific excluding Japan, Japan, and the Middle East and Africa.